R&D Pipeline
We are building a pipeline of transformative technologies based on our unique target of cell stress.
The Calrexin imaging product range is being followed by a range of emerging therapeutics, and diagnostics products that are under development:
CalRexin™ Imaging & Diagnostic Agents
CalRexin™:PET (Positron Emission Tomography) The potential for whole-body imaging of patients to identify programmed cell death, rather than having to remove cells from the body (biopsy), improves quality of life of cancer patients following radio- and chemotherapy treatment. CalRexin™:PET is an example of one of the diagnostic applications.